(Q46342504)
Statements
Trastuzumab and vinorelbine as highly effective and safe therapy for HER-2-overexpressing metastatic breast cancer. A single institution experience (English)
Vincenzo Di Lauro
Antonio Murrone
Ettore Bidoli
Maria D Magri
Diana Crivellari